Cargando…

Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation

IMPORTANCE: Increased utilization of hepatitis C virus (HCV)–positive liver allografts for liver transplant (LT) has been endorsed as one of several ways to combat national organ shortages. However, HCV-positive donors remain poorly characterized, and Organ Procurement and Transplantation Network re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Da, Ben L., Ezaz, Ghideon, Kushner, Tatyana, Crismale, James, Kakked, Gaurav, Gurakar, Ahmet, Dieterich, Douglas, Schiano, Thomas D., Saberi, Behnam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718602/ https://www.ncbi.nlm.nih.gov/pubmed/33275155 http://dx.doi.org/10.1001/jamanetworkopen.2020.27551

Ejemplares similares

The use of HCV positive donors among non-HCV infected liver transplant recipients
por: Zaffar, Duha, et al.
Publicado: (2022)

An Update on Usage of High-Risk Donors in Liver Transplantation
por: Muhammad, Haris, et al.
Publicado: (2021)

Regional and National Trends of Adult Living Donor Liver Transplantation in the United States Over the Last Two Decades
por: Alqahtani, Saleh A., et al.
Publicado: (2022)

Recurrence of hepatocellular carcinoma following deceased donor liver transplantation: case series
por: Simsek, Cem, et al.
Publicado: (2020)

Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation
por: Crismale, James F, et al.
Publicado: (2019)

Liver Transplantation for Hepatitis D Virus in the United States: A UNOS Study on Outcomes in the MELD Era
por: Kushner, Tatyana, et al.
Publicado: (2021)

Racial Disparities in Candidates for Hepatocellular Carcinoma Liver Transplant After 6-Month Wait Policy Change
por: Saberi, Behnam, et al.
Publicado: (2023)

Donor BMI and Post–living Donor Liver Transplantation Outcomes: A Preliminary Report
por: Lin, Jessica S., et al.
Publicado: (2023)

Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
por: Czarnecka, Paulina, et al.
Publicado: (2022)

Update on Immunosuppression in Liver Transplantation
por: Tasdogan, Burcak E, et al.
Publicado: (2019)

Recent advances in liver transplantation with HCV seropositive donors
por: Murag, Soumya, et al.
Publicado: (2019)

Recipient and Donor Outcomes After Living-Donor Liver Transplant for Unresectable Colorectal Liver Metastases
por: Hernandez-Alejandro, Roberto, et al.
Publicado: (2022)

Practice patterns and considerations in liver transplantation from living donors with high BMI: A review
por: Samaha, Carl, et al.
Publicado: (2023)

Donor DNA Utilization During Gene Targeting with Zinc-Finger Nucleases
por: Beumer, Kelly J., et al.
Publicado: (2013)

Survival Benefit of Living-Donor Liver Transplant
por: Jackson, Whitney E., et al.
Publicado: (2022)

Association Between Donor-Recipient Biological Relationship and Allograft Outcomes After Living Donor Kidney Transplant
por: Husain, S. Ali, et al.
Publicado: (2021)

Optimal Sequencing of Deceased Donor and Live Donor Kidney Transplant Among Pediatric Patients With Kidney Failure
por: Kiberd, Bryce A., et al.
Publicado: (2022)

Two Decades of Liver Transplants for Primary Biliary Cholangitis: A Comparative Study of Living Donors vs. Deceased Donor Liver Transplantations
por: Medina-Morales, Esli, et al.
Publicado: (2023)

Updated View on Kidney Transplant from HCV-Infected Donors and DAAs
por: Fabrizi, Fabrizio, et al.
Publicado: (2021)

Living-Donor Liver Transplant and Improved Post-Transplant Survival in Patients with Primary Sclerosing Cholangitis
por: Sierra, Leandro, et al.
Publicado: (2023)

Donor selection for lung transplant in Turkey: Is it necessary to wait for an ideal donor?
por: Vayvada, Mustafa, et al.
Publicado: (2021)

Liver Transplantation for Budd-Chiari Syndrome in the MELD Era
por: Alqahtani, Saleh A., et al.
Publicado: (2022)

An HCV‐positive recipient of an HCV‐positive donor liver successfully treated before and immediately after liver transplant with daclatasvir, sofosbuvir, and ribavirin
por: Poordad, Fred, et al.
Publicado: (2017)

Could the female-to-male transgender population be donor candidates for uterus transplantation?
por: Api, Murat, et al.
Publicado: (2017)

Utilization of Expanded Criteria Donors in Liver Transplantation
por: Saidi, Reza F.
Publicado: (2013)

Predictors of success of immediate tracheal extubation in living donor liver transplantation recipients()
por: Ibrahim, Douaa G.M., et al.
Publicado: (2021)

Early Outcomes of Adult Heart Transplantation From COVID-19 Infected Donors
por: Madan, Shivank, et al.
Publicado: (2023)

Donor Infection: An Opinion on Lung Donor Utilization
por: Garrity, Edward R., et al.
Publicado: (2005)

Tackling HCV-3 in Asia: Breakthroughs for Efficient and Cost-effective Treatment Strategies
por: Saeed, Naba, et al.
Publicado: (2016)

Management of HCV Infection and Liver Transplantation
por: Schiano, Thomas D., et al.
Publicado: (2006)

HCV RNA in serum and liver samples of patients undergoing living donor liver transplantation
por: Lin, Shu-Hsien, et al.
Publicado: (2021)

Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome
por: Nowak, Knut Michael, et al.
Publicado: (2016)

Organ Transplants From Deceased Donors With Primary Brain Tumors and Risk of Cancer Transmission
por: Greenhall, George H. B., et al.
Publicado: (2023)

Sofosbuvir/Velpatasvir Prophylaxis for 12 Weeks in Hepatitis C Virus (HCV)-Negative Recipients Receiving Kidney Transplantation from HCV-Positive Donors
por: Chen, Ruoyang, et al.
Publicado: (2021)

Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients
por: Duerr, Michael, et al.
Publicado: (2020)

Prevalence of HBV and HCV among blood donors in Kosovo
por: Fejza, Hajrullah, et al.
Publicado: (2009)

Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor
por: Stepanova, Maria, et al.
Publicado: (2016)

Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin
por: Sasaki, Reina, et al.
Publicado: (2016)

The Role of Donor Chronic Alcohol Abuse in the Development of Primary Graft Dysfunction in Lung Transplant Recipients
por: Pelaez, Andres, et al.
Publicado: (2015)

Association Between Declined Offers of Deceased Donor Kidney Allograft and Outcomes in Kidney Transplant Candidates
por: Husain, S. Ali, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5qfh78kmj4iiiriea2vbcoep0h